These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 31482507)
1. Understanding the Patient Perception of Statin Experience: A Qualitative Study. Vrablik M; Catapano AL; Wiklund O; Qian Y; Rane P; Grove A; Martin ML Adv Ther; 2019 Oct; 36(10):2723-2743. PubMed ID: 31482507 [TBL] [Abstract][Full Text] [Related]
2. Improving long-term adherence to statin therapy: a qualitative study of GPs' experiences in primary care. Krüger K; Leppkes N; Gehrke-Beck S; Herrmann W; Algharably EA; Kreutz R; Heintze C; Filler I Br J Gen Pract; 2018 Jun; 68(671):e401-e407. PubMed ID: 29686133 [TBL] [Abstract][Full Text] [Related]
3. The STatin Adverse Treatment Experience Survey: Experience of patients reporting side effects of statin therapy. Jacobson TA; Cheeley MK; Jones PH; La Forge R; Maki KC; López JAG; Xiang P; Bushnell DM; Martin ML; Cohen JD J Clin Lipidol; 2019; 13(3):415-424. PubMed ID: 31113745 [TBL] [Abstract][Full Text] [Related]
5. LIFESTAT - Living with statins: An interdisciplinary project on the use of statins as a cholesterol-lowering treatment and for cardiovascular risk reduction. Christensen CL; Wulff Helge J; Krasnik A; Kriegbaum M; Rasmussen LJ; Hickson ID; Liisberg KB; Oxlund B; Bruun B; Lau SR; Olsen MN; Andersen JS; Heltberg AS; Kuhlman AB; Morville TH; Dohlmann TL; Larsen S; Dela F Scand J Public Health; 2016 Jul; 44(5):534-9. PubMed ID: 26939591 [TBL] [Abstract][Full Text] [Related]
7. Provider recommendations for patient-reported muscle symptoms on statin therapy: Insights from the Understanding Statin Use in America and Gaps in Patient Education survey. Jacobson TA; Khan A; Maki KC; Brinton EA; Cohen JD J Clin Lipidol; 2018; 12(1):78-88. PubMed ID: 29239815 [TBL] [Abstract][Full Text] [Related]
8. DemographIc Assessment and EValuation of DEgree of Lipid Control in High Risk Indian DySlipidemia PatiEnts (DIVERSE Study). Malhotra N; Keshan MK; Agarwal A; Kumar RA; Trailokya A; Dalvi K; Talele S J Assoc Physicians India; 2016 Apr; 64(4):38-46. PubMed ID: 27734640 [TBL] [Abstract][Full Text] [Related]
9. Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries--Findings from the EUROASPIRE IV survey. Reiner Ž; De Backer G; Fras Z; Kotseva K; Tokgözoglu L; Wood D; De Bacquer D; Atherosclerosis; 2016 Mar; 246():243-50. PubMed ID: 26812002 [TBL] [Abstract][Full Text] [Related]
10. A Clinical Guide to Combination Lipid-Lowering Therapy. Russell C; Sheth S; Jacoby D Curr Atheroscler Rep; 2018 Mar; 20(4):19. PubMed ID: 29516190 [TBL] [Abstract][Full Text] [Related]
11. Amyotrophic lateral sclerosis-like conditions in possible association with cholesterol-lowering drugs: an analysis of patient reports to the University of California, San Diego (UCSD) Statin Effects Study. Golomb BA; Kwon EK; Koperski S; Evans MA Drug Saf; 2009; 32(8):649-61. PubMed ID: 19591530 [TBL] [Abstract][Full Text] [Related]
12. Risk identification and possible countermeasures for muscle adverse effects during statin therapy. Magni P; Macchi C; Morlotti B; Sirtori CR; Ruscica M Eur J Intern Med; 2015 Mar; 26(2):82-8. PubMed ID: 25640999 [TBL] [Abstract][Full Text] [Related]
13. Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada. Gitt AK; Drexel H; Feely J; Ferrières J; Gonzalez-Juanatey JR; Thomsen KK; Leiter LA; Lundman P; da Silva PM; Pedersen T; Wood D; Jünger C; Dellea PS; Sazonov V; Chazelle F; Kastelein JJ; Eur J Prev Cardiol; 2012 Apr; 19(2):221-30. PubMed ID: 21450578 [TBL] [Abstract][Full Text] [Related]
14. Optimizing Cholesterol Treatment in Patients With Muscle Complaints. Rosenson RS; Baker S; Banach M; Borow KM; Braun LT; Bruckert E; Brunham LR; Catapano AL; Elam MB; Mancini GBJ; Moriarty PM; Morris PB; Muntner P; Ray KK; Stroes ES; Taylor BA; Taylor VH; Watts GF; Thompson PD J Am Coll Cardiol; 2017 Sep; 70(10):1290-1301. PubMed ID: 28859793 [TBL] [Abstract][Full Text] [Related]
15. Patient Characteristics and Real-World Treatment Patterns Among Early Users of PCSK9 Inhibitors. Rane PB; Patel J; Harrison DJ; Shepherd J; Leith A; Bailey H; Piercy J Am J Cardiovasc Drugs; 2018 Apr; 18(2):103-108. PubMed ID: 28849360 [TBL] [Abstract][Full Text] [Related]
16. Lipids: a personal view of the past decade. Katsiki N; Mikhailidis DP Hormones (Athens); 2018 Dec; 17(4):461-478. PubMed ID: 30229482 [TBL] [Abstract][Full Text] [Related]
17. Statins in the treatment of dyslipidemia in the presence of elevated liver aminotransferase levels: a therapeutic dilemma. Calderon RM; Cubeddu LX; Goldberg RB; Schiff ER Mayo Clin Proc; 2010 Apr; 85(4):349-56. PubMed ID: 20360293 [TBL] [Abstract][Full Text] [Related]
18. Systematic review: comparative effectiveness and harms of combination therapy and monotherapy for dyslipidemia. Sharma M; Ansari MT; Abou-Setta AM; Soares-Weiser K; Ooi TC; Sears M; Yazdi F; Tsertsvadze A; Moher D Ann Intern Med; 2009 Nov; 151(9):622-30. PubMed ID: 19884623 [TBL] [Abstract][Full Text] [Related]
19. [Changes in the prevalence of statin use in Germany - findings from national health interview and examination surveys 1997-1999 and 2008-2011]. Knopf HC; Busch MA; Du Y; Truthmann J; Schienkiewitz A; Scheidt-Nave C Z Evid Fortbild Qual Gesundhwes; 2017 May; 122():22-31. PubMed ID: 28511896 [TBL] [Abstract][Full Text] [Related]
20. Gender differences in side effects and attitudes regarding statin use in the Understanding Statin Use in America and Gaps in Patient Education (USAGE) study. Karalis DG; Wild RA; Maki KC; Gaskins R; Jacobson TA; Sponseller CA; Cohen JD J Clin Lipidol; 2016; 10(4):833-841. PubMed ID: 27578114 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]